Atlas Trials

Topotecan, Cisplatin and Bevacizumab for Recurrent/Persistent Cervical Cancer

Clinical trial NCT00548418 · COMPLETED

Trial details

NCT number
NCT00548418
Sponsor
Washington University School of Medicine
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cervical Cancer
Start date
2007-02-01
Primary completion
2012-12-01
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.